Recursion Pharmaceuticals Inc.

NASDAQ: RXRX
Share price (6/27/25): $5.03
Market cap (6/27/25): $2.045 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

Prospectuses and Registrations Filter

Prospectus with selling stockholder info

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Prospectus with selling stockholder info

Ownership Filter

Michor Franziska

Hershberg Robert

Bumpus Namandje

News Filter

Shareholder Vote Results

Investor Presentation

Other Events, Financial Statements or Exhibits

Reports First Quarter 2025 Financial Results and Provides Business Update

Bolsters Board of Directors With Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Other Filter

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Scanned paper annual report submission